About us
German Hodgkin Study GroupSince 1978 and with more than 15,000 randomised patients the German Hodgkin Study Group aims to further optimize and standardize Hodgkin lymphoma diagnostics, treatment and follow-up care. On this side we would like to give you further information about Hodgkin lymphoma, current treatment strategies and the activities of the GHSG. The side aims to reach physicians as well as patients and interested laities. Get in touchIf you should miss any required information don’t hesitated to contact us. You will find an overview of responsible persons and our review institutes here. |
Die AVD-Rev Studie wurde bei älteren Hodgkin Lymphom Patienten im Alter von ≥ 60 bis ≤ 75 Jahre in mittleren und fortgeschrittenen Stadien ohne jegliche Vorbehandlung gestartet